Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APO vs APO + IDMTX/HDARA-C in Pediatric Large Cell Lymphoma
NCT00002618Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Dec 1994
- Primary completion
- Sep 2000
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of methotrexate and cytarabine in large-cell lymphoma (2 arms), sponsored by Children's Oncology Group. Primary endpoint: Event free survival. Started Dec 1994; status: completed.
02
Drugs
methotrexatecytarabine
03
Conditions
large-cell lymphoma
Beyond the preview
Go deeper on NCT00002618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002618.